Saudi pharma market crucial to country’s Vision 2030

25 Sep 2019

Plan in the kingdom is to raise the percentage of total pharmaceutical production to 40% from the current 20%.

The importance of Saudi Arabia’s pharmaceutical industry in the delivery of the country’s 2030 Vision was highlighted at CPhI Middle East & Africa.

Saudi pharma market crucial to country’s Vision 2030

During a presentation by Dr Faisal BinDail, Chairman of the National Committee for Pharmaceutical Industries, titled Delivering Saudi Arabia’s Vision 2030, a range of topics related to the pharmaceutical industry were discussed, including incentives for stimulating local manufacturing and the opportunities the emerging contract manufacturing sector present.

Dr BinDail said: “In the context of Saudi Arabia, pharma manufacturing holds an important position in achieving the Kingdom’s Vision 2030. The regulatory body, local industry players, global companies have realised the importance of this initiative and are working towards strengthening localised pharmaceutical manufacturing. Part of the transformation plan in the kingdom is to raise the percentage of total pharmaceutical production to 40% from the current 20%. The Government is supportive, local companies are gearing up and the regulatory body is encouraging, facilitating and providing incentives – thereby encouraging global companies to take advantage of this opportunity.

“Moreover, there is an enthusiasm among the local players to raise their standards and provide quality affordable medicines. Saudi Arabia is one of the few countries to adopt track and trace system to curb the menace of counterfeit.”

Saudi Arabia is the largest pharmaceutical market in the MENA region worth US$7.5 billion dollars and is expected to grow at a CAGR of around 5.5%.

“The market is dominated by branded products, as there is a preference for brands locally, but at the same time there is an opportunity for generics as well to expand. Around 20% of the pharma market is locally manufactured, while 80% is still imported from different countries, from the US, Europe, and different parts of the world, this is in brief how the pharmaceutical market in Saudi Arabia currently looks like,” added Dr BinDail.

Read More

Related news

Catalent to Partner with Ethicann on new fast-dissolve cannabinoid-based treatment

Catalent to Partner with Ethicann on new fast-dissolve cannabinoid-based treatment

4 Dec 2019

Program will initially focus on using Catalent’s orally disintegrating tablet technology to develop a combination pharmaceutical-grade CBD and THC product that, if approved, would treat patients suffering from MS spasticity.

Read more 
Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

4 Dec 2019

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

Read more 
Eli Lilly unveils shared innovation laboratory in San Francisco

Eli Lilly unveils shared innovation laboratory in San Francisco

3 Dec 2019

Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise.

Read more 
Ground-breaking work creates novel oil-in-water nanoemulsions

Ground-breaking work creates novel oil-in-water nanoemulsions

3 Dec 2019

New innovation has considerable potential to be used as a new environmentally friendly matrix for the microencapsulation and controlled release of a wide range of actives.

Read more 
UK experiences a 'baby boom' of new life sciences ventures

UK experiences a 'baby boom' of new life sciences ventures

2 Dec 2019

Unprecedented levels of investment cited as a major force driving the expansion.

Read more 
Pinpoint secures new investment to develop ground-breaking products

Pinpoint secures new investment to develop "ground-breaking" products

29 Nov 2019

The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.

Read more 
New single-use mixing system offers rapid and homogenous mixing

New single-use mixing system offers rapid and homogenous mixing

28 Nov 2019

ClearMixx performs liquid/liquid and powder/liquid mixing, with a dispersion plate able to efficiently mix the most challenging buffer, media and biopharmaceutical ingredients.

Read more 
Worldwide event predicts global pharma trends for 2020

Worldwide event predicts global pharma trends for 2020

27 Nov 2019

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

Read more 
UK’s life sciences sector continues to attract talent despite Brexit fear

UK’s life sciences sector continues to attract talent despite Brexit fear

26 Nov 2019

The largest area of growth has been within biotechnology companies, where job openings increased by 35%.

Read more 
Dr Reddy’s enters Nutrition Segment with diabetes drink

Dr Reddy’s enters Nutrition Segment with diabetes drink

25 Nov 2019

The company's diabetes nutrition drink, Celevida, is formulated to help manage blood glucose levels.

Read more